CompletedNot Applicable

Optical Frequency Domain Imaging for Non-melanoma Skin Cancers

United States10 participantsStarted 2017-03-01

Plain-language summary

The purpose of this research study is to find out if a non-invasive imaging device called Optical Frequency Domain Imaging (OFDI) can help doctors to see the tissue and blood vessels that are related to non-melanoma skin cancers. OFDI was designed to see microscopic details of your skin without needing to use any invasive techniques such as surgery or biopsy.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female subjects with Fitzpatrick skin type I-VI
✓. Subjects with ages between 18 and 80 years of age
✓. Presence of at least one NMSC lesion

Exclusion criteria

✕. Subjects with active localized or systemic infections
✕. Subjects participating in potentially confounding clinical studies of investigational therapies, either drug or device.
✕. Subjects taking any topical/systemic chemotherapy or immunosuppressants
✕. Subjects who are pregnant and/or breastfeeding
✕. Subjects with tape adhesive allergies

What they're measuring

Successful imaging of lesion

Timeframe: After completion of imaging session

Trial details

NCT IDNCT01662713

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-01

View on ClinicalTrials.gov More Non-Melanoma Skin Cancer (NMSC) trials